SEARCH

SEARCH BY CITATION

References

  • 1
    Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry . 2002; 159(4): 561566.
  • 2
    Suvisaari J, Perala J, Saarni SI, Härkänen T, Pirkola S, Joukamaa M, Koskinen S, Lönnqvist J, Reunanen A. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci . 2008; 258(3): 129136.
  • 3
    Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients: A review. Psychiatr Serv . 1996; 47(12): 13561363.
  • 4
    Ellingrod VL, Bishop JR, Moline J, Lin YC, Miller DD. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull . 2007; 40(1): 5762.
  • 5
    Ellingrod VL, Miller DD, Taylor SF, Moline J, Holman T, Kerr J. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res . 2008; 98(1–3): 4754.
  • 6
    Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, et al . Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia . 2007; 50(2): 431438.
  • 7
    Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, Driscoll I, Ferrucci L, Martin B, Mattson MP. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: Data from the baltimore longitudinal study of aging. PLoS One . 2010; 5(4): e10099.
  • 8
    Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: Findings in schizophrenia. Curr Opin Psychiatry . 2011; 24(2): 122127.
  • 9
    Rybakowski JK. BDNF gene: Functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics . 2008; 9(11): 15891593.
  • 10
    Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al . The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell . 2003; 112(2): 257269.
  • 11
    Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarolio L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A . 1999; 96(26): 1523915244.
  • 12
    Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, et al . Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet . 2010; 375(9716): 735742.
  • 13
    Tsai SJ. Statins may enhance the proteolytic cleavage of proBDNF: Implications for the treatment of depression. Med Hypotheses . 2007; 68(6): 12961299.
  • 14
    Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, Mahmood A, Zhou D. Chopp M. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma . 2008; 25(2): 130139.
  • 15
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia . 1985; 28(7): 412419.
  • 16
    Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I. Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes . 2006; 114(5): 249256.
  • 17
    Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care . 2003; 26(12): 33203325.
  • 18
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation . 2002; 106(25): 31433421.
  • 19
    Lahiri DK, Nurnberger JI, Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res . 1991; 19(19): 5444.
  • 20
    Marsh S, King CR, Garsa AA, McLeod HL. Pyrosequencing of clinically relevant polymorphisms. Methods Mol Biol . 2005; 311: 97114.
  • 21
    Britton KA, Mukamal KJ, Ix JH, Siscovick DS, Newman AB, de Boer IH, Thacker EL, Biggs ML, Gaziano JM, Djoussé L. Insulin resistance and incident peripheral artery disease in the cardiovascular health study. Vasc Med . 2012; 17: 8593.
  • 22
    Serfaty L, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, Drenth JP, Lonjon-Domanec I, Demasi R, Picchio G, et al . Insulin resistance and response to telaprevir plus peginterferon alpha and ribavirin in treatment-naive patients infected with HCV genotype 1. Gut . 2012; 61: 14731480.
  • 23
    Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis. Schizophr Res . 2010; 123(2–3): 225233.
  • 24
    Tsai A, Liou YJ, Hong CJ, Wu CL, Tsai SJ, Bai YM. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment. Neuromolecular Med . 2011; 13(4): 328333.
  • 25
    Zhang XY, Zhang WF, Zhou DF, Chen da C, Xiu MH, Wu HR, Haile DN, Kosten TA, Kosten TR. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Biol Psychiatry . 2012; 72: 700706.
  • 26
    Sasaki J, Iwashita M, Kono S. Statins: Beneficial or adverse for glucose metabolism. J Atheroscler Thromb . 2006; 13(3): 123129.
  • 27
    Nakata M, Nagasaka S, Kusaka I, Matsuoka H, Ishibashi S, Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): Implications in glycaemic control. Diabetologia . 2006; 49(8): 18811892.
  • 28
    Terracciano A, Piras MG, Lobina M, Mulas A, Meirelles O, Sutin AR, Chan W, Sanna S, Uda M, Crisponi L, et al . Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study. World J Biol Psychiatry . 2011 Nov 2 [Epub ahead of print].
  • 29
    Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab . 2008; 294(1): E15E26.
  • 30
    Rossner SM, Neovius M, Mattsson A, Marcus C, Norgren S. HOMA-IR and QUICKI: Decide on a general standard instead of making further comparisons. Acta Paediatr . 2010; 99(11): 17351740.